Quidel Closes Acquisition of Alere Triage, Natriuretic Peptide Assay Businesses

Oct 06, 2017

|

NEW YORK (360Dx) – Quidel said today that it has closed its previously announced acquisition of Alere's Triage MeterPro cardiovascular and toxicology business and its B-type natriuretic peptide (BNP) assay business.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Quidel Closes Acquisition of Alere Triage, Natriuretic Peptide Assay Businesses

To read the full story....

Breaking News

Hologic Fiscal Q1 Revenues Rise 89 Percent as Dx Testing Demand Surges

Spectrum Solutions, UCLA Partner to Study Saliva-Based Early-Stage Lung Cancer Detection

T2 Biosystems Preliminary Q4 Revenues Grow 155 Percent, Miss Estimates

Abbott Q4 Diagnostics Revenues Up 111 Percent, FY20 Revenues Up 9 Percent

Siemens Healthineers Q1 Diagnostics Revenues Rise 17 Percent on Pandemic-Related Demand

Abbott Panbio SARS-CoV-2 Rapid Antigen Test Nabs CE Mark for Asymptomatic Screening, Self-Collection

What's Popular?

Abbott Q4 Diagnostics Revenues Up 111 Percent, FY20 Revenues Up 9 Percent

Ambry Genetics Gets FDA Emergency Use Authorization for Coronavirus Test

Roche Renews Agreement to Distribute Sysmex Hematology Products

T2 Biosystems Preliminary Q4 Revenues Grow 155 Percent, Miss Estimates

Rhinostics Licenses Procter & Gamble Nasal Swab for COVID-19 Testing

Sponsorships